State Street Corp Neurocrine Biosciences Inc Transaction History
State Street Corp
- $2.47 Trillion
- Q4 2024
A detailed history of State Street Corp transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, State Street Corp holds 4,891,137 shares of NBIX stock, worth $533 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
4,891,137
Previous 5,148,293
4.99%
Holding current value
$533 Million
Previous $593 Million
12.64%
% of portfolio
0.03%
Previous 0.02%
Shares
20 transactions
Others Institutions Holding NBIX
# of Institutions
655Shares Held
96.6MCall Options Held
282KPut Options Held
281K-
Black Rock Inc. New York, NY14.2MShares$1.55 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.1 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA3.02MShares$329 Million0.26% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.54MShares$277 Million0.06% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.49MShares$271 Million0.54% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $10.4B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...